# Jeffrey A. Sparks

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jeffrey-a-sparks/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,746 |
| Field | Rheumatoid Arthritis Research and Therapies |
| h-index | 65 |
| i10-index | 217 |
| Last Known Institution | Brigham and Women's Hospital |
| OpenAlex ID | https://openalex.org/A5024906918 |
| ORCID iD | https://orcid.org/0000-0002-5556-4618 |
| Works | 438 |

## Researcher papers

- [Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host](https://scholariq.org/papers/persistence-and-evolution-of-sars-cov-2-in-an-immunocompromised-host/)
- [Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry](https://scholariq.org/papers/factors-associated-with-covid-19-related-death-in-people-with-rheumatic-diseases/)
- [Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry](https://scholariq.org/papers/associations-of-baseline-use-of-biologic-or-targeted-synthetic-dmards-with-covid/)
- [Adverse Effects of Low-Dose Methotrexate](https://scholariq.org/papers/adverse-effects-of-low-dose-methotrexate/)
- [A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19](https://scholariq.org/papers/a-rush-to-judgment-rapid-reporting-and-dissemination-of-results-and-its/)
- [2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases](https://scholariq.org/papers/2022-american-college-of-rheumatology-guideline-for-vaccinations-in-patients/)
- [<scp>SARS</scp>–<scp>CoV</scp>‐2 Infection and <scp>COVID</scp>‐19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta‐Analysis](https://scholariq.org/papers/scp-sars-scp-scp-cov-scp-2-infection-and-scp-covid-scp-19-outcomes-in-rheumatic/)

## Researcher topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Researcher university

- [Brigham and Women's Hospital](https://scholariq.org/institutions/brigham-and-women-s-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.